We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $347M
1-Year Est. Return 29.87%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
10 Year Est. Return
AUM
$174M
AUM Growth
+$8.06M
Cap. Flow
+$2.64M
Cap. Flow %
1.52%
Top 10 Hldgs %
51.49%
Holding
58
New
4
Increased
27
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$952K
2
MO icon
Altria Group
MO
+$201K
3
NYT icon
New York Times
NYT
+$197K
4
GE icon
GE Aerospace
GE
+$175K
5
FMC icon
FMC
FMC
+$159K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$340K
2
NFLX icon
Netflix
NFLX
+$211K
3
MTB icon
M&T Bank
MTB
+$206K
4
CPRT icon
Copart
CPRT
+$133K
5
AAPL icon
Apple
AAPL
+$44.2K

Sector Composition

Rank Sector Weight
1 Industrials 30.88%
2 Financials 15.21%
3 Technology 12.55%
4 Consumer Discretionary 12.02%
5 Healthcare 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$13.3M 7.67%
1,032,512
-8,888
-0.9% -$133K
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.07T
$9.26M 5.34%
43,268
+299
+0.7% +$61.3K
DE icon
3
Deere & Co
DE
$170B
$9.14M 5.27%
60,772
+743
+1% +$107K
AGM icon
4
Federal Agricultural Mortgage
AGM
$2.27B
$8.55M 4.93%
118,426
+746
+0.6% +$63.3K
TJX icon
5
TJX Companies
TJX
$170B
$8.49M 4.89%
151,502
+956
+0.6% +$49.1K
JNJ icon
6
Johnson & Johnson
JNJ
$635B
$8.31M 4.79%
60,145
+601
+1% +$79.9K
GD icon
7
General Dynamics
GD
$105B
$8.21M 4.73%
40,124
+185
+0.5% +$36.2K
KEYS icon
8
Keysight
KEYS
$54.5B
$8.17M 4.71%
123,221
+1,771
+1% +$110K
INGR icon
9
Ingredion
INGR
$6.38B
$8.12M 4.68%
77,403
+9,325
+14% +$952K
CNI icon
10
Canadian National Railway
CNI
$78.3B
$7.78M 4.49%
86,684
+803
+0.9% +$70.1K
HPQ icon
11
HP
HPQ
$23.5B
$7.65M 4.41%
296,801
+5,126
+2% +$124K
FMC icon
12
FMC
FMC
$1.42B
$7.53M 4.34%
99,626
+2,117
+2% +$159K
COF icon
13
Capital One
COF
$124B
$6.71M 3.87%
70,646
+852
+1% +$82.9K
APTV icon
14
Aptiv
APTV
$12B
$6.65M 3.83%
79,288
+1,683
+2% +$154K
CMI icon
15
Cummins
CMI
$91.7B
$5.83M 3.36%
39,936
+1,021
+3% +$144K
MIDD icon
16
Middleby
MIDD
$6.05B
$5.67M 3.27%
43,821
+795
+2% +$90.7K
LH icon
17
Labcorp
LH
$24.3B
$4.85M 2.79%
32,497
+757
+2% +$115K
NYT icon
18
New York Times
NYT
$11.6B
$4.7M 2.71%
203,215
+8,215
+4% +$197K
CL icon
19
Colgate-Palmolive
CL
$72.6B
$4.54M 2.61%
67,748
+1,315
+2% +$87.6K
DGX icon
20
Quest Diagnostics
DGX
$25.1B
$4.42M 2.55%
40,969
+850
+2% +$93.2K
PII icon
21
Polaris
PII
$4.15B
$4.16M 2.4%
41,185
+1,040
+3% +$116K
JKHY icon
22
Jack Henry & Associates
JKHY
$10.7B
$3.33M 1.92%
20,799
-275
-1% -$40.4K
TCP
23
DELISTED
TC Pipelines LP
TCP
$2.85M 1.64%
93,993
+822
+0.9% +$25.9K
XOM icon
24
ExxonMobil
XOM
$651B
$2.02M 1.17%
23,800
-278
-1% -$22.7K
AAPL icon
25
Apple
AAPL
$4.89T
$1.07M 0.62%
18,928
-848
-4% -$44.2K

Similar funds

Weybosset Research & Management's Q3 2018 Portfolio in Review

As of Q3 2018, Weybosset Research & Management held 58 positions worth $174M, up 4.9% from $165M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Weybosset Research & Management's Q3 2018 filing shows 4 new, 27 increased, 8 reduced and 3 closed positions. Its largest new stake was Altria Group: 3,384 shares worth $204K. The largest sale was AbbVie, an estimated $340K.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 30% a quarter earlier, followed by Financials and Technology.

  • Weybosset Research & Management's largest Q3 2018 buy was Altria Group: 3,384 shares worth $204K.
  • Weybosset Research & Management added most to Ingredion in Q3 2018, an estimated $952K increase.
  • Weybosset Research & Management's biggest Q3 2018 reduction was Copart, cutting an estimated $133K.
  • Weybosset Research & Management fully exited AbbVie in Q3 2018, selling an estimated $340K.
  • Weybosset Research & Management's ten largest holdings make up 51% of its $174M portfolio in Q3 2018.
  • Weybosset Research & Management opened 4 new positions and closed 3 in Q3 2018.
  • Weybosset Research & Management's portfolio value rose 4.9% quarter-over-quarter to $174M.

Based on Weybosset Research & Management's 13F filing for Q3 2018, filed 11 Oct 2018.